Finance

Lists
MED:NYSE
Medifast Inc
US$ ११.६७
+०.४३%
(+०.०५०) 1D
US$ ११.९१
+२.०६% (+०.२४)
After hours
Closed: अक्टोबर १३, १६:००:०४ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MED...
Open
US$ ११.६०
High
US$ ११.७९
Low
US$ ११.५१
Mkt. cap
१३.०५ करोड
Avg. vol.
१.१२ लाख
Volume
०.००
52-wk high
US$ १३.५८
52-wk low
US$ ९.२२
EPS
-US$ २.३३
Beta
०.६८
Shares outstanding
१.१२ करोड
No. of employees
३८०
Open
US$ ११.६०
High
US$ ११.७९
Low
US$ ११.५१
Mkt. cap
१३.०५ करोड
Avg. vol.
१.१२ लाख
Volume
०.००
52-wk high
US$ १३.५८
52-wk low
US$ ९.२२
EPS
-US$ २.३३
Beta
०.६८
Shares outstanding
१.१२ करोड
No. of employees
३८०
News stories
From web sources and news partners
Profile
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics. Wikipedia
About Medifast Inc
CEODaniel R. Chard | Daniel R. Chard
Employees३८०
Founded१९८१
Headquarters-
SectorPersonal care products
Analyst ratings
Based on 1 analyst giving stock ratings to MED in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for MED in the last 3 months
Highest
Current US$ ११.६७
US$ १२.०० (+२.८३%)
Average
US$ १२.०० (+२.८३%)
Lowest
US$ १२.०० (+२.८३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jim Salera
Stephens
Hold
Maintained
US$ १२.००
+२.८%
08/04/2026
Last report
२०२६ अगस्ट ३
Fiscal period
Q2 2026
-US$ ०.२८ / -US$ ०.६५
+५६.९२%beat
Revenue / Est. (USD)
७.६४ करोड / ७.२७ करोड
+५.०७%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
८.९४ करोड
७.५१ करोड
७.६० करोड
७.६४ करोड
Cost of goods sold
२.७२ करोड
२.३० करोड
२.४३ करोड
२.३० करोड
Cost of revenue
२.७२ करोड
२.३० करोड
२.४३ करोड
२.३० करोड
Research and development expenses
११.०० लाख
१०.०० लाख
११.०० लाख
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६.५१ करोड
५.८९ करोड
५.६१ करोड
५.७७ करोड
Operating expense
६.६२ करोड
५.९९ करोड
५.७२ करोड
५.७७ करोड
Total operating expenses
९.३५ करोड
८.२९ करोड
८.१५ करोड
८.०७ करोड
Operating income
-४०.८१ लाख
-७८.०३ लाख
-५४.७९ लाख
-४३.२७ लाख
Other non operating income
-२.०० हजार
१.०० हजार
१६.०० हजार
-११.०० हजार
EBT including unusual items
-२६.५७ लाख
-६३.८२ लाख
-१९.४१ लाख
-२९.९१ लाख
EBT excluding unusual items
-२६.५७ लाख
-६३.८२ लाख
-४०.८४ लाख
-२९.९१ लाख
Income tax expense
-३.९६ लाख
१.१७ करोड
१.८१ लाख
१.०९ लाख
Effective tax rate
१४.९०%
-१८३.९१%
-९.३२%
-३.६४%
Other operating expenses
-
-
-
-
Net income
-२२.६१ लाख
-१.८१ करोड
-२१.२२ लाख
-३१.०० लाख
Net profit margin
-२.५३%
-२४.१३%
-२.७९%
-४.०६%
Earnings per share
-०.२१
-१.६५
-०.१९
-०.२८
Interest and investment income
१४.२६ लाख
१४.२० लाख
१३.७९ लाख
१३.४७ लाख
Interest expense
-
-
-
-
Net interest expenses
१४.२६ लाख
१४.२० लाख
१३.७९ लाख
१३.४७ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-६.२९ लाख
-४३.३८ लाख
-१९.९६ लाख
-८.८१ लाख
Gain or loss from assets sale
६.०६ लाख
३.७२ लाख
-२१.२१ लाख
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू